Tender notice
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS EnglandTender value£441,994,547
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B. Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 05 - SOUTH of England Annual Tranche. Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 06 - Mids & East and North of England Regions - Bevacizumab. Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.